Jinxin Fertility Group Ltd
HKEX:1951

Watchlist Manager
Jinxin Fertility Group Ltd Logo
Jinxin Fertility Group Ltd
HKEX:1951
Watchlist
Price: 2.94 HKD -6.37% Market Closed
Market Cap: 8.1B HKD
Have any thoughts about
Jinxin Fertility Group Ltd?
Write Note

Jinxin Fertility Group Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jinxin Fertility Group Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Jinxin Fertility Group Ltd
HKEX:1951
Cash from Operating Activities
ÂĄ684.5m
CAGR 3-Years
30%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Cash from Operating Activities
ÂĄ1B
CAGR 3-Years
-14%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Cash from Operating Activities
ÂĄ861m
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
21%
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Cash from Operating Activities
ÂĄ939.3m
CAGR 3-Years
-22%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Dian Diagnostics Group Co Ltd
SZSE:300244
Cash from Operating Activities
ÂĄ1.6B
CAGR 3-Years
0%
CAGR 5-Years
22%
CAGR 10-Years
29%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Cash from Operating Activities
ÂĄ1.5B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Jinxin Fertility Group Ltd
Glance View

Market Cap
8.1B HKD
Industry
Health Care

Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.

Intrinsic Value
4.77 HKD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Jinxin Fertility Group Ltd's Cash from Operating Activities?
Cash from Operating Activities
684.5m CNY

Based on the financial report for Dec 31, 2023, Jinxin Fertility Group Ltd's Cash from Operating Activities amounts to 684.5m CNY.

What is Jinxin Fertility Group Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
14%

Over the last year, the Cash from Operating Activities growth was 26%. The average annual Cash from Operating Activities growth rates for Jinxin Fertility Group Ltd have been 30% over the past three years , 14% over the past five years .

Back to Top